CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (DDD-1.62%) and Desktop Metal (DM) entering the commercial bioprinting market this year. Bioprinting ...

New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...

The 3D printing company's recent acquisition marks its commercial entrance into the burgeoning bioprinting space, in which it had previously been involved only through a research collaboration. While ...

The 3D bioprinting of an ear from living tissue is no trivial achievement. Reconstruction of ears has been done before with adults, but this is a quite different bio environment, effectively creating ...

Researchers in Germany have created a groundbreaking 3D printer designed to print living tissue in the body through tiny ...

3D bioprinting technology has managed to accomplish something that's never been done before: depict an actual, active tumor in its entirety. The 3D bioprinter developed in Russia stands on a table ...

"Organoids are set to become essential tools in medical research. The research program financed by SATT AxLR and the support of CTIBIOTECH, in this key stage, will enable Cilcare to accelerate the ...

Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (NYSE: DDD) and Desktop Metal (NYSE: DM) entering the commercial bioprinting market this year.